Form 8-K - Current report:
SEC Accession No. 0001823239-25-000002
Filing Date
2025-01-08
Accepted
2025-01-08 16:12:07
Documents
14
Period of Report
2025-01-02
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K mrvi-20250102.htm   iXBRL 8-K 32547
2 EX-99.1 mrvi-pressreleaseq42024pre.htm EX-99.1 11045
  Complete submission text file 0001823239-25-000002.txt   175007

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT mrvi-20250102.xsd EX-101.SCH 1782
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT mrvi-20250102_lab.xml EX-101.LAB 22548
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT mrvi-20250102_pre.xml EX-101.PRE 13046
16 EXTRACTED XBRL INSTANCE DOCUMENT mrvi-20250102_htm.xml XML 2833
Mailing Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121
Business Address 10770 WATERIDGE CIRCLE SUITE 200 SAN DIEGO CA 92121 (858) 546-0004
MARAVAI LIFESCIENCES HOLDINGS, INC. (Filer) CIK: 0001823239 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39725 | Film No.: 25518674
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)